Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian CancerQiangsheng Zhang, Luoting Yu, Guoquan Wan et al.|Journal of Medicinal Chemistry|2023Cited by 24